Clinical Trial Update: Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema [Phase 2]

View source ↗

Summary

Phase 2 dosing study of ranibizumab for diabetic retinopathy and macular edema has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Retina Vitreous Associates of Florida | Conditions: Diabetic Retinopathy, Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2019-05-17